Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReSScue: ACHIM in Systemic Sclerosis
NCT03444220Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2018
- Primary completion
- May 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing ACHIM with Placebo (2 arms). Primary endpoint: Clinical SSc-related GI parameters at 16 weeks. Started Jan 2018; status: completed.
02
Drugs
anaerobically cultivated human intestinal microbiota
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT03444220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03444220.